Understanding Legal Age Limits for Purchasing E-Cigarettes

Aug.31.2022
The age of purchasing and using electronic cigarettes varies between countries, with the US recently changing to 21 years old. Restrictions aim to prevent underage use.

Over the past decade, electronic cigarettes have experienced rapid development, becoming the most popular category of tobacco products and a common solution for those trying to quit smoking. However, with their increasing popularity has come a problematic group of customers – curious minors. Regulatory agencies and legislators have implemented various strategies to prevent young people from using electronic cigarettes, with the most common approach being age restrictions on purchasing these products.

 

Similar to alcohol, mandating a minimum age for the sale of electronic cigarettes is not a perfect solution, but it remains the most reliable method for reducing youth use. Legislators are tasked with determining the age at which individuals can legally purchase e-cigarettes. However, punishing retailers who violate the law and enforcing the regulations can prove challenging. Mistakes in enforcement may inadvertently increase smoking among young people or adults or contribute to the creation of a black market.

 

In most countries, electronic cigarettes are either regulated as tobacco products or as a separate consumer product category, or are not regulated at all. In some countries, electronic cigarette products are prohibited. In countries where they are regulated, the legal age to purchase electronic cigarettes is usually the same as the legal age of majority. In most countries, this age is 18 years old, but as we will see, the situation varies, for example in the US, the largest electronic cigarette market in the world, the legal age to use electronic cigarettes is 21 years old.

 

What is the legal age for purchasing and using e-cigarettes in the United States?

 

In response to pressure from tobacco control groups and concerned parents, Congress passed the new 21st federal tobacco law in December 2019. The law was included in the year-end federal appropriation bill, signed into law by President Trump on December 20th, and went into effect immediately. While it encompasses both cigarettes and other tobacco products, the driving force behind this legislation was concern over youth use of e-cigarettes.

 

The bill adds a provision to the Food, Drug, and Cosmetic Act stating that it is illegal for any retailer to sell tobacco products to anyone under the age of 21. It mandates that each state enforce age restrictions or risk losing some federal drug abuse grant money. The new law does not penalize individuals under the age of 21 for purchasing, using, or possessing tobacco products (usually referred to as "PUP laws"), but only imposes fines on retailers who sell to underage customers.

 

Advocating for the Tobacco Control Act on the 21st.

 

In 2016, the FDA determined that it was federally prohibited to sell electronic cigarette products to those under 18 years of age. By classifying smokeless devices and e-liquids as tobacco products, they automatically fell under existing federal restrictions. The minimum age for purchasing e-cigarettes has been a core demand of tobacco control activists who have long described the e-cigarette market as a "wild west" in need of FDA regulation. The truth is not quite as exciting: at the time federal action was taken, 48 states already had their own age restrictions in place.

 

The legal age for electronic cigarettes varies across countries worldwide.

 

With the exception of countries that have banned electronic cigarettes and those without regulations surrounding them, the majority of nations simply use the legal age of adulthood to set the minimum age for purchasing electronic cigarette products (as well as other adult products).

 

Some countries have a national legal age but allow individual states or provinces to set a higher legal age. For example, Canada's national minimum age is 18, but many provinces and territories have set the age of 19 as the legal age to purchase e-cigarette products. In Australia, the sale of nicotine-containing products (excluding cigarettes) without a doctor's prescription is illegal, but the use of non-nicotine e-cigarettes is allowed and the purchasing age varies by state.

 

If you plan to bring electronic cigarette products to another country, it is wise to contact the authorities of that country before departing to learn about the latest information on electronic cigarette laws and practices.

 

Countries where the legal age for electronic cigarettes is 18 years old:

 

Belgium, Bhutan, Brazil, Bulgaria, Canada, China, Costa Rica, Croatia, Cyprus, Denmark, Ecuador, England, El Salvador, Estonia, Fiji, Finland, France, Georgia, Germany, Greece, Israel, Italy, Ivory Coast, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Moldova, Netherlands, New Zealand, Norway, Papua New Guinea, Paraguay, Poland, Portugal, San Marino, Saudi Arabia, Scotland, Senegal, Slovenia, South Africa, Sweden, Tajikistan, Togo, Tuvalu, Ukraine, Vietnam, Wales.

 

The legal age for purchasing electronic cigarettes is 19 years old in this country.

 

Jordan, South Korea, and Turkey.

 

Countries where the legal age for e-cigarette consumption is 20 years old:

 

Japan

 

Country with legal vaping age of 21 years old:

 

Ethiopia, Guam, Honduras, the Republic of Palau, the Philippines, and the United States (source: the Johns Hopkins University Global Tobacco Control website, Knowledge-Action-Change Global Tobacco Harm Reduction website, and VAPING360 survey)

 

Who knows when adulthood truly begins?

 

No one knows exactly when adolescence ends or adulthood begins - in fact, it varies for each person. However, lawmakers must decide on a legal age of majority that allows young people to vote, sign contracts, apply for credit, serve in the military, and purchase age-restricted products such as alcohol, tobacco, and other items considered inappropriate for children.

 

Age is always a compromise, but it acknowledges that we allow adults to make many risky choices. The U.S. 21 Tobacco Law is a special law because it considers smoking (and vaping) too risky to the point where cigarettes (and e-cigarettes) must be taken away from young people. Most countries in the world have not found enough evidence to support the necessity of taking such extreme measures.

 

Statement.

 

This article is compiled from third-party information and is for industry exchange and learning purposes only.

 

This article does not represent the views of 2FIRSTS, and the company is unable to confirm the authenticity or accuracy of the content. The translation of this article is solely intended for industry-related exchange and research purposes.

 

Due to limitations in our translation abilities, this article may not exactly reflect the original text. Please refer to the original article for accuracy.

 

2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or international issues and positions.

 

The compilation of information is the property of the original media and authors. If there is any copyright infringement, please contact us for deletion.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
VAPORESSO introduced the PRIX MTL pod system in August 2026 in two versions, Filter and NFC. The Filter version allows users to switch between a conventional drip tip and a filter tip, while the NFC version links interchangeable panels to matching on-screen animations. PRIX features a 2,600mAh battery, a 5.5ml pod, a 0.87-inch TFT display and a maximum output of 40W, alongside Dual Mesh Impact Pods capable of operating at two resistance and power configurations. VAPORESSO's French website lists MSRP at $39.99 for the Filter version and $49.90 for the NFC version.
Market
Aug.24 by 2Firsts Perspectives
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02